Prosecution Insights
Last updated: July 05, 2026
Application No. 17/972,785

Multi-Member Bone Structure Prostheses

Final Rejection §112
Filed
Oct 25, 2022
Priority
Jul 27, 2010 — provisional 61/368,233 +7 more
Examiner
SUMMITT, LYNNSY M
Art Unit
3773
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Tenon Medical Inc.
OA Round
2 (Final)
68%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
468 granted / 686 resolved
-1.8% vs TC avg
Strong +44% interview lift
Without
With
+43.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
21 currently pending
Career history
702
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
63.3%
+23.3% vs TC avg
§102
12.1%
-27.9% vs TC avg
§112
5.4%
-34.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 686 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the first and second osteotome engagement rails extending from the open proximal end to the closed distal end of the elongated members and the elongated members having a uniform width from the open proximal end to the closed distal end, as claimed in claim 1 must be shown or the feature(s) canceled from the claim(s). No new matter should be entered. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-4, 6-8, 10, 12-14, 16-19 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 recites the limitation “a first osteotome engagement rail that extends from said first open proximal end to said first closed distal end of the first elongated member” in lines 15-16. However, the osteotome engagement rail disclosed in the originally filed application does not extend to the closed distal end. Rather, it ends before reaching the distal end, as shown in figure 4D and 4E. Claim 1 recites the limitation “said first elongated member further comprising a uniform width from said first open proximal end to said closed distal end” (lines 17-18). However, as shown in figures 4D and 4E in the disclosure as originally filed, the width of the elongated members varies along the length. In particular, in the proximal and distal end regions. Claim 1 recites the limitation “a second osteotome engagement rail that extends from said second open proximal end to said second closed distal end of the first elongated member” in lines 30-31. However, the osteotome engagement rail disclosed in the originally filed application does not extend to the closed distal end. Rather, it ends before reaching the distal end, as shown in figure 4D and 4E. Claim 1 recites the limitation “said second elongated member further comprising a uniform width from said second open proximal end to said second closed distal end” (lines 33 and 34). However, as shown in figures 4D and 4E in the disclosure as originally filed, the width of the elongated members varies along the length. In particular, in the proximal and distal end regions. Response to Arguments Applicant’s arguments with respect to claim(s) 1-4, 6-8, 10, 12-14, 16-19 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Lynnsy Summitt whose telephone number is (571)270-78567856. The examiner can normally be reached on Monday through Thursday from 8am until 5pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Eduardo Robert, at (571) 272-4719. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LYNNSY M SUMMITT/Primary Examiner, Art Unit 3773
Read full office action

Prosecution Timeline

Oct 25, 2022
Application Filed
Oct 10, 2023
Response after Non-Final Action
Dec 24, 2025
Response after Non-Final Action
Mar 09, 2026
Response after Non-Final Action
Apr 09, 2026
Non-Final Rejection mailed — §112
Apr 14, 2026
Response Filed
Jun 11, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12648797
ARTICULATING CONNECTORS, SYSTEMS, AND METHODS THEREOF
3y 9m to grant Granted Jun 09, 2026
Patent 12636047
POP-ON-CAP ASSEMBLIES HAVING OPPOSING SPLAY-RESISTING FEATURES AND OPPOSING ANTI-ROTATION FEATURES FOR SPINAL SURGERY
4y 8m to grant Granted May 26, 2026
Patent 12622730
METHOD OF PLACING AN IMPLANT BETWEEN BONE PORTIONS
3y 6m to grant Granted May 12, 2026
Patent 12582528
Systems for Sacroiliac Joint Stabilization
3y 9m to grant Granted Mar 24, 2026
Patent 12582529
Sacroiliac Joint Stabilization Prostheses
3y 6m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+43.8%)
3y 5m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 686 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month